NB Oncology Health Day Symposium

Register
1 May 2026
8:35 AM TO 4:10 PM (AST)
Marriot Delta Beausejour
Moncton, NB
ABOUT

New Brunswick Oncology Health Day planning committee invites you to register below for the 2026 symposium taking place on May 1, 2026.

The purpose of this symposium is to bring the greater New Brunswick oncology community together to foster learning and knowledge exchange in the facilitation of patient care.

The 2026 conference will focus on breast cancer. The ultimate goal of the program is to facilitate learning and bridge potential gaps in the treatment of cancer, ensuring we stay ahead in the dramatically evolving oncology landscape.

If you are an HCP involved in the treatment and management of breast cancer, you are invited to attend this full-day symposium as we facilitate learning and bridge potential gaps in treatment, while staying ahead in the evolving oncology landscape.

0
DAYS
0
HOURS
0
MINS
0
SEC
WHAT'S ON
What to expect
Join us for a day of learning and collaboration on breast cancer treatment and care for healthcare professionals.
Opening Remarks and a Breast Cancer Patient Testimonial
00
To kick off the conference, Dr. Mohammed Harb will conduct a short fireside chat with a breast cancer patient.
Current Updates In Breast Cancer: A Multidisciplinary Look at Disease and Treatment Updates
01
Hear from presenters Dr. Jean-Francois Boileau, Dr. Farah Naz, Dr. Pierre Whitlock, Dr. Christine Brezden-Masley, Dr. Gillian Bethune, and Glenn Myers with section moderators Dr. Heather Tait, Alexi Surette, Dr. Maged Salem, and Dr. Mohammed Harb
Innovative Practices in Breast Cancer Treatment and Management
02
Hear from presenters Dr. Husam Abdel-Qadir, Dr. Jamil Asselah , Dr. Mahmoud Abdelsalam, Nathalie Bolduc, and Dr. Saly Zhara, with section moderators Dr. Thais Megid, Dr. Stacie Connors, Dr. Melanie Boucher,Dr. Tooraj Shakerinia, and Dr. Mohammed Harb

Agenda

SECTION 0
8:30 AM - 8:40 AM (AST)

Opening Remarks by Conference Chair

Dr. Mohammed Harb, Medical Oncologist at Dr. Sheldon H. Rubin Oncology Clinic, Moncton, NB

8:40 AM - 8:55 AM (AST)

A Breast Cancer Patient Testimonial

Dr. Mohammed Harb conducts a short fireside chat with a breast cancer patient.

SECTION 1

Current Updates In Breast Cancer

8:55 AM - 9:25 AM (AST)

Surgical Updates in Breast Cancer

Dr. Jean-Francois Boileau, Surgical Oncologist, Jewish General Hospital, Montreal, QC. Learn surgical perspectives and latest clinical data, including de-escalation strategies.

9:25 AM - 9:55 AM (AST)

Updates in Radiological Treatment of Patients with Breast Cancer

Dr. Farah Naz, Radiation Oncologist, Saint John Regional Hospital, Saint John, NB. Explore radiological management, clinical endpoints, and de-escalation strategies.

9:55 AM - 10:10 AM (AST)

Networking Break and Sponsor Booth Visitation

Opportunity to network and visit sponsor booths. Hosted by Dr. Pierre Whitlock, Medical Oncologist, Dr. Sheldon H. Rubin Oncology Clinic, Moncton, NB.

10:10 AM - 10:50 AM (AST)

Current Updates in the Treatment of Breast Cancer Patients with Systemic Therapies

Dr. Christine Brezden-Masley, Medical Oncologist, Marvelle Koffler Breast Centre at Mount Sinai Hospital, Toronto, ON. Case-based review of systemic therapies and treatment strategies.

Learning Objectives — After participating in this session participants will be able to:

  • Assess and interpret the treatment of breast cancer from a medical oncologist perspective.
  • Recognize the role of the latest and most significant systemic therapies updates in breast cancer via case-based analysis.
  • Interpret the latest data and clinically relevant endpoints in the systemic treatment of breast cancer.
10:50 AM - 11:20 AM (AST)

A Review of Pathology and Biomarkers in Breast Cancer

Dr. Gillian Bethune, Anatomical Pathologist, QEII, Halifax, NS. Review biomarker testing strategies and implementation barriers.

Learning Objectives — After participating in this session participants will be able to:

  • Assess the role of biomarker testing in breast cancer.
  • Explore and evaluate current testing strategies to improve patient outcomes.
  • Recognize barriers for implementation of biomarker testing.
11:20 AM - 11:45 AM (AST)

Supportive Care in the Management of Breast Cancer

Glenn Myers, Oncology Pharmacist, Dr. Sheldon H. Rubin Oncology Clinic, Moncton, NB. Explore supportive management and patient/HCP tools.

Learning Objectives — After participating in this session participants will be able to:

  • Assess and interpret the supportive management of breast cancer from a pharmacist perspective.
  • Recognize the role of the oncology pharmacist in the medical management of breast cancer
  • Review new and innovative patient and HCP tools in the management of breast cancer.
11:45 AM - 12:30 PM (AST)

Section 1: Expert Panel - Best Practices and Q&A

Panel: Dr. Jean-Francois Boileau, Dr. Christine Brezden-Masley, Dr. Farah Naz, Glenn Myers, Dr. Gillian Bethune

Moderator: Dr. Mohammed Harb. Review section learnings and discuss best practices via interactive discussion.

12:30 PM - 1:05 PM (AST)

Lunch Break and Sponsor Booth Visitation

Time to eat and network with attendees and sponsors.

SECTION 2

Innovative Practices in Breast Cancer Treatment and Management

1:05 PM - 1:35 PM (AST)

The Emerging Field of Cardio-Oncology

Dr. Husam Abdel-Qadir, Cardiologist, Cleveland Clinic Canada, Toronto, ON. Learn the role of cardio-oncology and multidisciplinary care strategies.

Learning Objectives — After participating in this session participants will be able to:

  • Recognize the role of the cardio-oncology in the medical management of breast cancer.
  • Defining the roles of key multidisciplinary team members involved in cardio-oncology care.
  • Reviewing strategies to complex clinical case scenarios involving patients with co-existing cancer and cardiovascular disease.
1:35 PM - 2:05 PM (AST)

The Emerging Utilization of AI in Breast Cancer

Dr. Jamil Asselah, Medical Oncologist, McGill University Health Centre, Montreal, QC. Explore AI applications in breast cancer management.

Learning Objectives — After participating in this session participants will be able to:

  • Recognize the emerging role of the artificial intelligence as it applies to the medical management of breast cancer.
2:05 PM - 2:30 PM (AST)

Innovations in Systemic Treatment Delivery: Subcutaneous Immunotherapy

Dr. Mahmoud Abdelsalam, Medical Oncologist, Dr. Sheldon H. Rubin Oncology Clinic, Moncton, NB. Discuss rationales, local experiences, and logistics of subcutaneous therapies.

Learning Objectives — After participating in this session participants will be able to:

  • Discuss rationales behind transition to subcutaneous immunotherapies.
  • Review local experiences with transition to subcutaneous immunotherapies.
  • Examine logistical aspects of transitioning to subcutaneous immunotherapies.
2:30 PM - 2:45 PM (AST)

Networking Break and Sponsor Booth Visitation

Opportunity to network and visit sponsor booths.

2:45 PM - 3:10 PM (AST)

Clinical Genetics in Breast Cancer

Nathalie Bolduc, Geneticist and Clinical Researcher. Review current research and implementation opportunities in clinical genetics for breast cancer.

Learning Objectives — After participating in this session participants will be able to:

  • Explore and evaluate current research and expertise in clinical genetics as it applies to breast cancer.
  • Recognize opportunities and barriers for implementation of identifying and addressing genetic disease in breast cancer patients.
3:10 PM - 3:35 PM (AST)

Innovative Approaches to Diagnostics in Breast Cancer

Dr. Saly Zhara, Diagnostic Radiologist, The Moncton Hospital, Moncton, NB. Review innovative diagnostic research and practices.

Learning Objectives — After participating in this session participants will be able to:

  • Review innovative research and practices in diagnostic radiology.
3:35 PM - 4:25 PM (AST)

Section 2: Expert Panel - Best Practices and Q&A

Panel: Dr. Mahmoud Abdelsalam, Dr. Jamil Asselah, Dr. Husam Abdel-Qadir

Moderator: Dr. Mohammed Harb. Discuss section learnings and best practices in patient care via interactive discussion.

4:25 PM - 4:30 PM (AST)

Closing Remarks by Conference Chair

Dr. Mohammed Harb, Medical Oncologist, Dr. Sheldon H. Rubin Oncology Clinic, Moncton, NB.

Scientific & Planning Commitee

Dr. Mohammed Harb

Dr. Mohammed Harb

Medical Oncologist - TMH Moncton, NB

Dr. Melanie Boucher

Dr. Melanie Boucher

Medical Oncologist - QEH Charlottetown, PE

Dr. Mahmoud Abdelsalam

Dr. Mahmoud Abdelsalam

Medical Oncologist - TMH Moncton, NB

Dr. Pierre Whitlock

Dr. Pierre Whitlock

Medical Oncologist - TMH Moncton, NB

Dr. Maged Salem

Dr. Maged Salem

Medical Oncologist - TMH Moncton, NB

Dr. Stacie Connors

Dr. Stacie Connors

Medical Oncologist - DEC Fredericton, NB

Verna Welling

Verna Welling

TMH Moncton, NB

Dr. Thais Megid

Dr. Thais Megid

Medical Oncologist - GDH Moncton, NB

Dr. Julie Arsenault

Dr. Julie Arsenault

Radiation Oncologist - GDH Moncton, NB

Feedback